Cardinal Health sells China pharma business for $1.2 billion
DUBLIN, Ohio — Cardinal Health Inc. plans to sell its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co. Ltd. for $1.2 billion. Cardinal said the agreement, announced late Tuesday, includes its pharmaceutical and medical products distribution business in China but not its other businesses there, including Cordis, the recently acquired Patient Recovery business, its
